• Link to Facebook
  • Link to Instagram
  • Link to X
  • Home
  • Members
  • En Español
  • Contact
National Cancer Institute Clinical Oncology Research Program
SCOR - Southeast Clinical Oncology Research Consortium
  • Clinical Trials
  • Find a Doctor
  • About SCOR
    • Become a Member
  • Resources
    • Videos
    • Articles
    • Community Members
    • Community Support Groups
    • FAQs
    • Patient Resources
  • Menu Menu
  • Home
  • Members
  • En Español
  • Clinical Trials
  • Find a Clinical Trial Doctor
  • About SCOR
    • About SCOR
    • Become a Member of SCOR
  • Resources
    • Videos
    • News
    • Community Members
    • Community Support Groups
    • Clinical Trials FAQ
    • Clinical Trial Patient Resources
  • Contact SCOR
  • Privacy Policy
  • Site Map

Stage IV Survivor’s Ongoing Clinical Trial Success

January 15, 2020/in Clinical Trial, Clinical Trial Success

From Pancreatic Cancer Action Network
By Kristin Reynolds, Jan. 14, 2020

Pancreatic cancer clinical trial participant Earl Groce at his son's wedding

Earl Groce with his wife, Juanita, at their son’s wedding. Groce was best man.

Earl Groce couldn’t believe it when his doctor told him that he had pancreatic cancer.

It was stage IV.

“I’ve always had pretty darn good luck,” he said to the doctor. “I believe it’s just run out.”

Today, four-plus years later, he feels differently.

Earl Groce enjoys time with his family, including three grandchildren.Groce has been a part of a clinical trial since his diagnosis, and the results, he said, “have been tremendous.”

Just recently, his MRI and CT scan (he’s had around 25 of each) revealed continued good results – no sign of cancer. His CA 19-9 levels remain in a normal range – also a good sign.

At 72, Groce has had 98 rounds of chemotherapy through a clinical trial for CPI-613, a targeted therapy aimed at cancer cell metabolism. He receives the test drug in addition to FOLFIRINOX, a combination of three chemotherapeutic agents.

Pancreatic cancer patients who participate in clinical research have better outcomes. Every treatment available today was approved through a clinical trial. The Pancreatic Cancer Action Network (PanCAN) strongly recommends clinical trials at diagnosis and during every treatment decision.

Groce joined the clinical trial as a phase I study participant. The study is currently in phase III.

“If you get a chance to enroll in a clinical trial, please consider it,” is Groce’s message to others fighting pancreatic cancer. “Do it for your sake and the sake of future patients.”

Since the diagnosis, Groce, a grandfather of three (with another one on the way), has watched them “get four years older,” stood beside his son as the best man at his wedding, taken a slew of road trips, bought a condo on an N.C. beach and celebrated 51 years of marriage to his wife Juanita.

“I want to see thousands of pancreatic cancer patients have the same great life after diagnosis that I’ve had,” he said.

He knows his diagnosis is not cause for celebration, but being alive certainly is.

“Nothing changes your attitude like being told, ‘You are going to die pretty soon.’

“So every time someone says to me, ‘Have a good day!’ I respond that EVERY day is a good day.”

Share this entry
  • Share on Facebook
  • Share on X
  • Share on Pinterest
  • Share on LinkedIn
  • Share by Mail
https://southeastclinicaloncology.org/wp-content/uploads/2018/06/SCOR-Southeast-Clinical-Oncology-Research_Logo.png 0 0 BCeditor https://southeastclinicaloncology.org/wp-content/uploads/2018/06/SCOR-Southeast-Clinical-Oncology-Research_Logo.png BCeditor2020-01-15 14:45:282020-01-15 14:46:12Stage IV Survivor’s Ongoing Clinical Trial Success
You might also like
pancreatic cancer clinical trial Diversity Lacking in Pancreatic Cancer Trials
pancreatic cancer clinical trial Understanding Clinical Trials
pancreatic cancer clinical trial FirstHealth Is World Leader in Lung Cancer Care Through Use of Robotic Technology
pancreatic cancer clinical trial Multiple Myeloma Clinical Trial Benefits

A program of the National Cancer Institute of the National Institutes of Health

Community Resources

FAQ's

Participating SCOR Members

  • Cary, NC
  • Charleston, SC
  • Charlotte, NC
  • Chesapeake, VA
  • Florence, SC
  • Fort Myers, FL
  • Gastonia, NC
  • Goldsboro, NC
  • Greensboro, NC
  • Hendersonville, NC – Pardee
  • Hendersonville, NC – Advent Health
  • Kingsport, TN
  • Martinsville, VA
  • New Bern, NC
  • Pinehurst, NC
  • Richmond, VA
  • Rocky Mount, NC
  • Savannah, GA
  • Wilmington, NC
  • Winston Salem, NC

Contact SCOR

Southeast Clinical Oncology
Research Consortium

2150 Country Club Road,
Suite 200
Winston Salem, NC 27104
T: (336) 448-1417
F: (336) 448-1425

Member Communities

Cary, NC
Charleston, SC
Charlotte, NC
Chesapeake, VA
Florence, SC
Fort Myers, FL
Gastonia, NC
Goldsboro, NC
Greensboro, NC
Hendersonville, NC – Pardee
Hendersonville, NC – AdventHealth
Kingsport, TN
Martinsville, VA
New Bern, NC
Pinehurst, NC
Richmond, VA
Rocky Mount, NC
Savannah, GA
Syracuse, NY
Wilmington, NC
Winston-Salem, NC

National Cancer Institute Clinical Oncology Research Program, Grant #5UG1CA-189858. All content © Southeast Clinical Oncology Research Consortium. All rights reserved. 2150 Country Club Road, Suite 200, Winston-Salem, NC 27104-4241 | Phone: (336) 448-1417 | Fax: (336) 448-1425 | Site Map | Privacy Policy | Website Design by Built Creative.
  • Link to Facebook
  • Link to Instagram
  • Link to X
Link to: FirstHealth Clinical Trials Make Impact Link to: FirstHealth Clinical Trials Make Impact FirstHealth Clinical Trials Make Impact Link to: Understanding Clinical Trials Link to: Understanding Clinical Trials Understanding Clinical Trials
Scroll to top Scroll to top Scroll to top